SWEDEN – Anglo-Swedish pharmaceutical company, AstraZeneca has appointed Handelsbanken to run a new Swedish fixed income portfolio within its SKr2.3bn (€243.3m) pension fund.

The fixed income element of AstraZeneca’s pensions assets accounts for SKr920m, which is 40% of the fund’s total assets.

The mandate will be run out of the new pension foundation that AstraZeneca is setting up in Sweden, whilst the pension fund’s equities element will continue to be managed from the existing UK AstraZeneca pension fund.

Topics